AIDriven Layoffs Market Reaction May Be Less Positive Than Expected New York Fed Study Reveals Disproportionate Impact of Rising Gas Prices on LowerIncome Households US House Foreign Affairs Committee Chair Warns of Chinas Growing Role in Argentina Contract Bid Berkshire Hathaway Portfolio Update New Stakes in Delta Air Lines and Alphabet Artificial Intelligence Reshapes Quarterly Earnings Landscape A Broad Perspective Bloom Energy Surges After 26 Billion Fuel Cell Deal with AI Cloud Provider Nebius Nordson NDSN Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower Hut 8 Corp HUT Q3 2024 Earnings EPS Beats Estimates Despite Continued Losses CHRW Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Signals bioAffinity Technologies BIAF Q3 2025 Earnings Significant EPS Miss as Revenue Remains Zero Stock Declines 37 Sachem Capital SACH Q4 2025 Earnings EPS Surges 782 Above Estimates Shares Decline Despite Strong Bottom Line Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage DLocal DLO Dips 188 as Support Levels Come Into Focus Sharps Technology Inc Warrant STSSW Holds Steady at 004 Amid Low Volatility FACT II Acquisition Corp Unit FACTU Holds Steady at 1145 Amidst SPAC Market Consolidation Deutsche Bank DB Edges Lower Amid Market Uncertainty Key Levels to Watch HDFC Bank Shows Modest Uptick as Support Holds Firm SP 500 Edges Higher as Healthcare and Technology Lead BroadBased Gains TXRH Q1 2026 Earnings EPS Beats Estimates by 10 Stock Rises 26 Knowles Corporation KN Surges 387 as Stock Approaches Key Resistance Level NTIC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances NIO Q1 2026 Earnings EPS Beat Masks Continued Operational Challenges Oxford Industries Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Quarter KAPA Q1 2026 Earnings EPS Misses Estimates as Development Expenses Weigh CLGN Q4 2025 Earnings Widening Losses Yet Shares Edge Higher on Pipeline Progress Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue